-
Mashup Score: 0
JACC: CardioOncology’s three-part series provides evidence-based guidance and highlights gaps in evidence for the cardiovascular care of patients before, during, and after cancer therapy. Explore each below: JACC: CardioOncology. 2024 Oct, 6 (5) 631–654 JACC: CardioOncology. 2024 Dec, 6 (6) 815–834 JACC: CardioOncology. 2025 Jan 7 (1) 1-19 JACC: CardioOncology’s societal statements and proceedings provides expert consensus, guidelines, and discussions that addresses the intersection of cancer treatment
Source: www.jacc.orgCategories: General Medicine NewsTweet
-
Mashup Score: 6
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes has evidenced-based recommendations on PCI, Revascularization, Anticoagulants
Source: www.jacc.orgCategories: General Medicine News, Cardiology News and JournTweet-
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines https://t.co/2j59GVw6ye https://t.co/Nw41rY6juF
-
-
Mashup Score: 0
Contribute to cardiovascular care by nominating yourself for ACC and AHA committees. Open to all professionals, including early career and international experts.
Source: www.jacc.orgCategories: General Medicine News, Cardiology News and JournTweet-
Calling for applications to join the writing and peer-review committees for cardiovascular clinical practice guidelines. Individuals from all career stages, all cardiovascular disciplines, and geographical regions are encouraged to apply. Learn more https://t.co/Wk7D8HCA4h https://t.co/55YqdLws5l
-
-
Mashup Score: 1The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity: - 20 day(s) ago
AbstractCardiovascular (CV) toxicity from cancer therapy is a significant and growing concern. Conventional oncology clinical trial designs focused solely on cancer treatment efficacy have not prov…
Source: www.jacc.orgCategories: General Medicine NewsTweet-
The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity https://t.co/ajqwu4xwZ6 @JACCJournals https://t.co/H3nrJoQcz2
-
-
Mashup Score: 11BSE and BCOS Guideline for Transthoracic Echocardiographic Assessment of Adult Cancer Patients Receiving Anthracyclines and/or Trastuzumab: - 21 day(s) ago
AbstractThe subspecialty of cardio-oncology aims to reduce cardiovascular morbidity and mortality in patients with cancer or following cancer treatment. Cancer therapy can lead to a variety of card…
Source: www.jacc.orgCategories: General Medicine NewsTweet-
The British Society of Echocardiography & BCOS Guideline for Transthoracic Echocardiographic Assessment of Adult Cancer Patients Receiving Anthracyclines and/or Trastuzumab https://t.co/mjwsMbdI0R @JACCJournals https://t.co/SlJzeQhOxv
-
-
Mashup Score: 63
AbstractRadiation therapy is a cornerstone of cancer therapy, with >50% of patients undergoing therapeutic radiation. As a result of widespread use and improved survival, there is increasing focus …
Source: www.jacc.orgCategories: General Medicine NewsTweet-
Cardiovascular Manifestations From Therapeutic Radiation: A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology Society https://t.co/reYzSs71VT @JACCJournals https://t.co/Qy89gbmZAe
-
-
Mashup Score: 1Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art Review - 23 day(s) ago
AbstractDespite improvements in cancer survival, cancer therapy–related cardiovascular toxicity has risen to become a prominent clinical challenge. This has led to the growth of the burgeoning fiel…
Source: www.jacc.orgCategories: General Medicine NewsTweet-
Through this symposium-based review, authors can highlight the knowledge gaps and clinical priorities to inform the design of future studies that aim to prevent and mitigate cardiovascular disease in cancer patients and survivors https://t.co/zR108OLTwG @JACCJournals https://t.co/QbuLT0hDV7
-
-
Mashup Score: 0
AbstractThe development of novel treatments has improved cancer outcomes but may result in cardiovascular toxicities. Traditional approaches to clinical trial safety evaluation have limitations in …
Source: www.jacc.orgCategories: General Medicine NewsTweet-
Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology Primer https://t.co/0qtFywjUb5 @JACCJournals https://t.co/Mkx1FkWTiT
-
-
Mashup Score: 1
Acknowledgement of Country
Source: www.heartlungcirc.orgCategories: General Medicine NewsTweet-
National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Comprehensive Australian Clinical Guideline for Diagnosing and Managing Acute Coronary Syndromes 2025 https://t.co/hk1q0pmwMD https://t.co/2y4LhlAz4I
-
-
Mashup Score: 6
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes has evidenced-based recommendations on PCI, Revascularization, Anticoagulants
Source: www.jacc.orgCategories: General Medicine News, Cardiology News and JournTweet-
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines https://t.co/2j59GVw6ye https://t.co/Nw41rY6juF
-
Highlights From Expert Panel on Gaps & Recommendations Cancer Therapy's. JACC: CardioOncology’s series provides evidence-based guidance & highlights gaps in evidence for the cardiovascular care of patients before, during, and after cancer therapy. https://t.co/UOwWpiQZiX https://t.co/ZjXzU2cueQ